Pomegranate Peel Extract for Primary Molar Pulpotomy
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age4-7
SponsorTanta University
About this trial
Pomegranate peel extract has demonstrated a range of potential uses in the biomedical industry in recent years because of its numerous benefits, which include anti-inflammatory, antibacterial, anti-apoptotic, antioxidant, and cell-regeneration-promoting qualities. Therefore, the purpose of this study will be to evaluate the clinical and radiographic efficacy of Pomegranate peel extract as a pulpotomy agent in primary teeth.
Eligibility criteria
Qualifiers
Restorable primary molars with deep carious lesions.
Absence of gingival swelling or sinus tract.
Absence of spontaneous pain
Absence of pain on percussion.
Disqualifiers
presence of spontaneous pain
presence of gingival swelling or sinus tract
presence of internal or external root resorption
pain on percussion.
Trial design
Treatments tested in this trial
- Pulpotomy
- Radiation
Treatment groups
30 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov